PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
+6.72%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.28B
AUM Growth
+$2.28B
(+3.6%)
Cap. Flow
+$54M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
20.2%
Holding
1,671
New
56
Increased
627
Reduced
876
Closed
111
Top Buys
| 1 |
Apple
AAPL
|
$36.9M |
| 2 |
CELG
Celgene Corp
CELG
|
$16.5M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$15.6M |
| 4 |
Intel
INTC
|
$15.1M |
| 5 |
Exxon Mobil
XOM
|
$7.11M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$21M |
| 2 |
Amgen
AMGN
|
$14.3M |
| 3 |
AbbVie
ABBV
|
$14.1M |
| 4 |
Biogen
BIIB
|
$12.1M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.04M |
Sector Composition
| 1 | Healthcare | 24.97% |
| 2 | Technology | 13.71% |
| 3 | Energy | 10.18% |
| 4 | Financials | 7.95% |
| 5 | Communication Services | 6.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $83.1M | 3.64% | 1,001,839 -252,967 | -20% | -$21M |
|
|
2
Amgen
AMGN
$155B
| $58.6M | 2.57% | 494,806 -120,664 | -20% | -$14.3M |
|
|
3
AbbVie
ABBV
$372B
| $54.1M | 2.37% | 957,997 -249,572 | -21% | -$14.1M |
|
|
4
Biogen
BIIB
$19.4B
| $48.6M | 2.13% | 154,233 -38,354 | -20% | -$12.1M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $44.9M | 1.97% | 522,930 +192,185 | +58% | +$16.5M |
|
|
6
Apple
AAPL
$3.45T
| $43.8M | 1.92% | 471,735 +396,666 | +528% | +$36.9M |
|
|
7
Exxon Mobil
XOM
$487B
| $34.2M | 1.5% | 340,027 +70,571 | +26% | +$7.11M |
|
|
8
Alphabet (Google) Class C
GOOG
$2.58T
| $33.7M | 1.48% | 58,152 +26,881 | +86% | +$15.6M |
|
|
9
Intel
INTC
$107B
| $33.2M | 1.46% | 1,075,965 +487,861 | +83% | +$15.1M |
|
10
Microsoft
MSFT
$3.77T
| $26.3M | 1.15% | 630,550 -53,344 | -8% | -$2.22M |
|
11
Johnson & Johnson
JNJ
$427B
| $25.9M | 1.14% | 247,874 -9,898 | -4% | -$1.04M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $20.3M | 0.89% | 129,802 -32,278 | -20% | -$5.04M |
|
13
Chevron
CVX
$324B
| $20M | 0.88% | 153,415 +31,295 | +26% | +$4.09M |
|
14
Schlumberger
SLB
$55B
| $19M | 0.83% | 161,368 +50,736 | +46% | +$5.98M |
|
15
Amazon
AMZN
$2.44T
| $17M | 0.75% | 52,488 -5,645 | -10% | -$1.83M |
|
16
Pfizer
PFE
$141B
| $16.4M | 0.72% | 552,795 -23,586 | -4% | -$700K |
|
17
Meta Platforms (Facebook)
META
$1.86T
| $15.5M | 0.68% | 230,307 -23,218 | -9% | -$1.56M |
|
18
Regeneron Pharmaceuticals
REGN
$61.5B
| $15.1M | 0.66% | 53,606 -11,091 | -17% | -$3.13M |
|
19
Merck
MRK
$210B
| $14.8M | 0.65% | 255,945 -12,269 | -5% | -$710K |
|
20
Illumina
ILMN
$15.8B
| $14.7M | 0.64% | 82,346 -21,018 | -20% | -$3.75M |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $14.6M | 0.64% | 154,233 -38,354 | -20% | -$3.63M |
|
22
Freeport-McMoran
FCX
$63.7B
| $13M | 0.57% | 356,971 +105,061 | +42% | +$3.83M |
|
23
Wells Fargo
WFC
$263B
| $11M | 0.48% | 209,691 -64,983 | -24% | -$3.42M |
|
24
Texas Instruments
TXN
$184B
| $11M | 0.48% | 230,589 +105,253 | +84% | +$5.03M |
|
25
Comcast
CMCSA
$125B
| $10.5M | 0.46% | 195,462 -15,956 | -8% | -$856K |
|